Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Journal of Clinical Medicine
|
July 2, 2021
The CRBN, CUL4A and DDB1 Expression Predicts the Response to Immunomodulatory Drugs and Survival of Multiple Myeloma Patients
Joanna Barankiewicz, Anna Szumera-Ciećkiewicz, Aleksander Salomon-Perzyński, et al.
Cell Death & Disease
|
October 10, 2023
SIRT1 and HSP90α feed-forward circuit safeguards chromosome segregation integrity in diffuse large B cell lymphomas
Emilia Białopiotrowicz-Data, Monika Noyszewska-Kania, Ewa Jabłońska, et al.
International Journal of Molecular Sciences
|
November 27, 2024
Characterization and Experimental Use of Multiple Myeloma Bone Marrow Endothelial Cells and Progenitors
Filip Garbicz, Marcin Kaszkowiak, Julia Dudkiewicz-Garbicz, et al.
Cells
|
April 3, 2021
Epithelial Cells of Deep Infiltrating Endometriosis Harbor Mutations in Cancer Driver Genes
Agnieszka Koppolu, Radosław B Maksym, Wiktor Paskal, et al.
Blood Cancer Journal
|
July 15, 2026
The role of RAD23A in DNA repair and proteasome-dependent protein degradation in multiple myeloma
Xueping Wan, Ting Du, Teng Fang, et al.
Science Advances
|
April 29, 2022
A novel β-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancer
Helen Tanton, Tomasz Sewastianik, Hyuk-Soo Seo, et al.
Blood
|
February 3, 2026
Proteasome Subunit PSMD1 is a Key Therapeutic Target in Multiple Myeloma
Ting Du, Teng Fang, Sindhu C Pillai, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
Paclitaxel-induced mitotic arrest results in a convergence of apoptotic dependencies that can be safely exploited by BCL-X<sub>L</sub> degradation to overcome cancer chemoresistance
Xingping Qin, Adam Presser, Lissah Johnson, et al.
Scientific Reports
|
November 17, 2022
Targeting arginase-1 exerts antitumor effects in multiple myeloma and mitigates bortezomib-induced cardiotoxicity
Kavita Ramji, Tomasz M Grzywa, Anna Sosnowska, et al.
Cell Death & Disease
|
December 26, 2025
PIM kinase inhibition attenuates pro-tumoral and immunosuppressive functions of macrophages in classic Hodgkin lymphoma
Maciej Szydłowski, Ewa Kurtz, Filip Garbicz, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Journal of Clinical Medicine
|
July 2, 2021
The CRBN, CUL4A and DDB1 Expression Predicts the Response to Immunomodulatory Drugs and Survival of Multiple Myeloma Patients
Joanna Barankiewicz, Anna Szumera-Ciećkiewicz, Aleksander Salomon-Perzyński, et al.
Cell Death & Disease
|
October 10, 2023
SIRT1 and HSP90α feed-forward circuit safeguards chromosome segregation integrity in diffuse large B cell lymphomas
Emilia Białopiotrowicz-Data, Monika Noyszewska-Kania, Ewa Jabłońska, et al.
International Journal of Molecular Sciences
|
November 27, 2024
Characterization and Experimental Use of Multiple Myeloma Bone Marrow Endothelial Cells and Progenitors
Filip Garbicz, Marcin Kaszkowiak, Julia Dudkiewicz-Garbicz, et al.
Cells
|
April 3, 2021
Epithelial Cells of Deep Infiltrating Endometriosis Harbor Mutations in Cancer Driver Genes
Agnieszka Koppolu, Radosław B Maksym, Wiktor Paskal, et al.
Blood Cancer Journal
|
July 15, 2026
The role of RAD23A in DNA repair and proteasome-dependent protein degradation in multiple myeloma
Xueping Wan, Ting Du, Teng Fang, et al.
Science Advances
|
April 29, 2022
A novel β-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancer
Helen Tanton, Tomasz Sewastianik, Hyuk-Soo Seo, et al.
Blood
|
February 3, 2026
Proteasome Subunit PSMD1 is a Key Therapeutic Target in Multiple Myeloma
Ting Du, Teng Fang, Sindhu C Pillai, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
Paclitaxel-induced mitotic arrest results in a convergence of apoptotic dependencies that can be safely exploited by BCL-X<sub>L</sub> degradation to overcome cancer chemoresistance
Xingping Qin, Adam Presser, Lissah Johnson, et al.
Scientific Reports
|
November 17, 2022
Targeting arginase-1 exerts antitumor effects in multiple myeloma and mitigates bortezomib-induced cardiotoxicity
Kavita Ramji, Tomasz M Grzywa, Anna Sosnowska, et al.
Cell Death & Disease
|
December 26, 2025
PIM kinase inhibition attenuates pro-tumoral and immunosuppressive functions of macrophages in classic Hodgkin lymphoma
Maciej Szydłowski, Ewa Kurtz, Filip Garbicz, et al.
Page
of 3